TREACE MEDICAL CONCEPTS INC. - COMMON STOCK

Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure

02 2 2024 11:00:00 提供 Nasdaq GlobeNewswire

Treace to Highlight Latest Product Innovations and ALIGN3D™ Study Outcomes at the 2024 ACFAS Annual Scientific Conference

01 2 2024 06:00:00 提供 Nasdaq GlobeNewswire

Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2023 Revenue

08 1 2024 06:00:00 提供 Nasdaq GlobeNewswire

Treace to Present at 42nd Annual J.P. Morgan Healthcare Conference

19 12 2023 06:00:00 提供 Nasdaq GlobeNewswire

Treace Medical Concepts Reports Third Quarter 2023 Financial Results

09 11 2023 15:05:01 提供 Nasdaq GlobeNewswire

Treace to Present at Stifel 2023 Healthcare Conference

30 10 2023 06:00:00 提供 Nasdaq GlobeNewswire

Treace to Report Third Quarter 2023 Financial Results

16 10 2023 06:00:00 提供 Nasdaq GlobeNewswire

Treace Highlights New Product Innovations and Updated ALIGN3D™ Clinical Study Data at the American Orthopaedic Foot & Ankle Society Annual Meeting 2023

20 9 2023 06:00:00 提供 Nasdaq GlobeNewswire

Treace Medical Concepts Announces New Patent Covering Instrumented Bunion Correction Procedures and Milestone 50th U.S. Patent

14 9 2023 15:05:00 提供 Nasdaq GlobeNewswire

Treace Medical Concepts Announces Limited Market Release of New Complementary Technologies for Treating Bunions and Related Procedures

11 9 2023 15:05:00 提供 Nasdaq GlobeNewswire

Treace Announces Participation in the 21st Annual Morgan Stanley Global Healthcare Conference

22 8 2023 15:05:00 提供 Nasdaq GlobeNewswire

Treace Medical Concepts Appoints Nathan Minnich as Senior Vice President, Marketing

21 8 2023 06:00:00 提供 Nasdaq GlobeNewswire

Treace to Report Second Quarter 2023 Financial Results on August 8, 2023

18 7 2023 15:15:00 提供 Nasdaq GlobeNewswire

Treace Appoints Julie Dewey as Chief Communications and Investor Relations Officer

12 7 2023 15:15:00 提供 Nasdaq GlobeNewswire

Treace Medical Completes Acquisition of Technology Enabling Patient Specific Instrumentation and Reports on Clinical Cases Using PSI with the Lapiplasty® System

13 6 2023 15:15:00 提供 Nasdaq GlobeNewswire

Treace Medical Concepts to Acquire Technology Enabling Patient Specific Instrumentation for Foot and Ankle Surgeries

01 6 2023 15:15:00 提供 Nasdaq GlobeNewswire

Treace Medical Concepts Reports First Quarter 2023 Financial Results

08 5 2023 15:05:01 提供 Nasdaq GlobeNewswire

Treace Announces Participation in the Bank of America 2023 Healthcare Conference

26 4 2023 15:15:00 提供 Nasdaq GlobeNewswire

Treace to Report First Quarter 2023 Financial Results on May 8, 2023

20 4 2023 15:15:00 提供 Nasdaq GlobeNewswire

Treace Medical Expands Market Leading Global IP Portfolio For Bunion And Related Deformities

19 4 2023 15:15:00 提供 Nasdaq GlobeNewswire